FDA Inspection 1237367 — Jamie D. Weisman, MD
The FDA completed an inspection of Jamie D. Weisman, MD on April 12, 2024 in Sandy Springs, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sandy Springs, GA (United States)
Additional Details
Clinical Investigator (CI)